Visa Inc vs 22nd Century Group Inc — how do they compare? Visa Inc trades at $384.45 (market cap $704.20B), while 22nd Century Group Inc trades at $0.84 (market cap $621.67K). The key difference: Visa Inc is far larger — about 1132755.3× 22nd Century Group Inc's market cap, and Visa Inc pays a 0.71% dividend while 22nd Century Group Inc pays none. Which is the better fit depends on your goals.
| V | XXII | |
|---|---|---|
Market Cap | $704.20B | $621.67K |
Volume | 6,405,857 | 45,625 |
Sector | Financials | Consumer Staples |
52-Week High | $384.14 | $483.00 |
52-Week Low | $295.52 | $0.80 |
Enterprise Value | $714.78B | -$3.69M |
Dividend Yield | 0.71% | — |
Typical Hold Time | — | 32 Days |
Signals from Pluang's Aura AI — not financial advice
Visa (V) trades at $383.79, up 3.14% today, showing strong momentum near its 52-week high. The stock maintains bullish technical signals with consistent earnings beats and robust fundamentals, including 50.78% net margins and 61.79% ROE. Recent developments include AI-powered commerce initiatives and stablecoin partnerships, positioning Visa at the forefront of payment innovation while maintaining dominant market positioning.
Visa presents a compelling investment case with strong analyst support (85% buy ratings) and a $422.24 price target offering 10% upside. However, elevated valuation multiples (P/E 31.92) and emerging fintech competition require monitoring. The company's consistent execution and AI integration provide growth catalysts, though regulatory scrutiny and payment disruption risks remain considerations for investors.
22nd Century Group (XXII) trades at $0.89, down 0.94% today, with a bearish technical signal despite oversold RSI readings. The company shows severe financial stress with negative gross margins of -54.6% and net income margin of -76.01%, though valuation metrics appear low with P/S of 0.09 and P/B of 0.03. Recent news highlights regulatory progress in nicotine reduction initiatives and expanded retail distribution for VLN products.
While analyst consensus remains bullish with 75% buy ratings and a $1,240 price target, fundamental challenges persist with consecutive earnings misses and negative cash flow from operations. The stock presents high-risk speculation on regulatory adoption of reduced-nicotine standards, requiring careful risk assessment given the company's ongoing losses and cash burn.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Visa Inc. operates a retail electronic payments network and manages global financial services. The Company also offers global commerce through the transfer of value and information among financial institutions, merchants, consumers, businesses, and government entities.
Read more on V →22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.
Read more on XXII →